Thank you!
Your email has been successfully added to our mailing list.
CLOSE
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Sign up
Log in
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
URGN
News
URGN –
urogen pharma ltd
(US:NASDAQ)
DELAYED
<
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
——
URGN
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
8/4
08:00 am
urgn
UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate Developments
Low
REPORT
7/28
04:00 pm
urgn
UroGen Pharma Announces License and Supply Agreement with Neopharm to Pursue Regulatory Approval and Commercialization for Jelmyto® in Israel
Low
REPORT
7/28
08:00 am
urgn
UroGen Pharma to Report Second Quarter 2021 Financial Results on Wednesday, August 4, 2021
Low
REPORT
7/20
11:37 am
urgn
UroGen Pharma Ltd. (
NASDAQ: URGN
) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
Low
REPORT
7/14
10:01 am
urgn
UroGen Pharma sees Q2 net revenue of $13M, above consensus [Seeking Alpha]
Low
REPORT
7/14
08:00 am
urgn
UroGen Pharma Reports Strong Preliminary Jelmyto® Sales for Second Quarter 2021
Low
REPORT
7/7
08:00 am
urgn
UroGen Pharma to Present at Ladenburg Thalmann Healthcare Conference
Low
REPORT
6/4
08:00 am
urgn
UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
REPORT
5/25
08:00 am
urgn
UroGen Pharma Announces June 2021 Conference Schedule
Medium
REPORT
5/13
02:01 pm
urgn
UroGen Pharma Ltd. (URGN) CEO Liz Barrett on Q1 2021 Results - Earnings Call Transcript [Seeking Alpha]
Low
REPORT
5/13
07:30 am
urgn
UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments
High
REPORT
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day